entertainment -WSS

entertainment

author：knowledge 2025-09-28 19:25:07 - browse：78132

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Gritstone Bio's cancer vaccine test, and more on Novartis' deal

WSS

Cue Health's Covid

A protest over insulin prices is seen as a fight for life

Melinda French Gates resigns from Gates Foundation

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Devoted Health’s losses in Medicare Advantage persist

Key Senate committee drafts bipartisan bill to stem drug shortages

entertainment

entertainment

explore

The cancer drug shortage isn’t new — and neither are the solutions

Cano Health’s bankruptcy is a warning for Medicare Advantage

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Q&A: Jennifer Adair on making gene therapy available globally

New air purifier tech could be key to improving indoor air quality

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Jerome Adams on the need for new antivirals for Covid

Global cancer cases to surge 77% by 2050, WHO report says

The cancer drug shortage isn’t new — and neither are the solutions

H5N1 bird flu virus started spreading in cows in Texas in December

focus

Gene therapy for Afghan refugees’ infant will be fully covered

What’s missing from the debate over nursing home staff minimums

Diversity in clinical trials starts with building trust, experts say

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Key Senate committee drafts bipartisan bill to stem drug shortages

Problems with a popular proposal to regulate AI in health care

Wikipedia

Wikipedia

hotspot

hotspot